Provigil and Nuvigil Linked To Major Congenital Birth Defects: Study

|

The findings of a new study raise serious concerns about the potential side effects of Provigil and Nuvigil use during pregnancy, indicating the narcolepsy drugs may increase the risk of fetal malformation birth defects.

Researchers from Israel published a research letter this week in the medical journal JAMA Internal Medicine, which warns the rate of major congenital malformations was more than four times higher for births by women taking one of the two drugs than the rate of the general population.

Provigil (modafinil) and Nuvigil (armodafinil) are designed to treat narcolepsy, which is a chronic sleep disorder that causes overwhelming daytime drowsiness. However, the medications are often used off-label to improve cognitive performance, researchers noted. Provigil was first approved for use by the FDA in 1998. Nuvigil was first approved by the FDA in 2007. Both medications are sold by Teva Pharmaceuticals, which sponsored the study.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

In 2013 a Nuvigil and Provigil registry was created to track pregnancy and fetal outcomes associated with use of the two drugs. Researchers used data from that registry to track major malformations in this latest research letter.

Researchers used data from 102 prospective live births recorded by the registry between 2013 and 2019. According to the data, they found that 13% of those cases involved major congenital malformations. That is more than four times higher than the rate of 3% among the children of those who did not use either of the narcolepsy drugs.

Among the children born with malformations, three had congenital heart malformations, which, at a prevalence of three percent, is three times higher than the rate of heart malformations among the general populace, which is 1%.

Both drugs are controlled substances in the U.S. due to the risk of abuse and addiction. In addition, they are pregnancy category C drugs, due to the risk of spontaneous abortions and other potential pregnancy risks. However, malformation data has only come from animal studies until now.

The FDA currently recommends both drugs be used during pregnancy only if the potential benefits are greater than the potential side effects.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Ocaliva, promoted as a treatment to prevent liver injury, has been recalled following reports of high rates of liver damage and patient deaths.
Women are sharing alarming reports of pain, infections, and reconstruction failures caused by internal bra mesh implants like GalaFLEX, as the FDA confirms these devices were never approved for breast surgery and lawsuits now allege manufacturers failed to warn about the risks.